Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

More Than Skin Deep: Lethargy and Diaphoresis in the Morning.

Finkelstein RA, Mody K, Traube C, Blei F.

Pediatr Emerg Care. 2018 Dec;34(12):e246-e250. doi: 10.1097/PEC.0000000000001683. No abstract available.

PMID:
30507758
2.

Severe hypernatremia in an adolescent with an eating disorder.

Weiner EA, Finkelstein RA, Goldstein MA, Gupta N, Noviski N, Sharma A.

Adolesc Med State Art Rev. 2012 Aug;23(2):371-80. Review. No abstract available.

PMID:
23162946
3.

Development and testing of low-volume hyperoncotic, hyperosmotic spray-dried plasma for the treatment of trauma-associated coagulopathy.

Shuja F, Finkelstein RA, Fukudome E, Duggan M, Kheirbek T, Hamwi K, Fischer TH, Fikry K, deMoya M, Velmahos GC, Alam HB.

J Trauma. 2011 Mar;70(3):664-71. doi: 10.1097/TA.0b013e31820e83be.

PMID:
21610357
4.

Cholera, Vibrio cholerae O1 and O139, and Other Pathogenic Vibrios.

Finkelstein RA.

In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 24.

5.

Treatment with histone deacetylase inhibitor attenuates MAP kinase mediated liver injury in a lethal model of septic shock.

Finkelstein RA, Li Y, Liu B, Shuja F, Fukudome E, Velmahos GC, deMoya M, Alam HB.

J Surg Res. 2010 Sep;163(1):146-54. doi: 10.1016/j.jss.2010.04.024. Epub 2010 May 10.

6.

Surviving lethal septic shock without fluid resuscitation in a rodent model.

Li Y, Liu B, Fukudome EY, Kochanek AR, Finkelstein RA, Chong W, Jin G, Lu J, deMoya MA, Velmahos GC, Alam HB.

Surgery. 2010 Aug;148(2):246-54. doi: 10.1016/j.surg.2010.05.003. Epub 2010 Jun 19.

7.

Alterations in gene expression after induction of profound hypothermia for the treatment of lethal hemorrhage.

Alam HB, Hashmi S, Finkelstein RA, Shuja F, Fukudome EY, Li Y, Liu B, Demoya M, Velmahos GC.

J Trauma. 2010 May;68(5):1084-98. doi: 10.1097/TA.0b013e3181d76bd1. Erratum in: J Trauma. 2010 Jul;69(1):242. Frankelstein, Robert A [corrected to Finkelstein, Robert A].

PMID:
20453763
8.

Induced hypothermia for trauma: current research and practice.

Finkelstein RA, Alam HB.

J Intensive Care Med. 2010 Jul;25(4):205-26. doi: 10.1177/0885066610366919. Epub 2010 May 5. Review.

PMID:
20444735
9.

Protective effect of suberoylanilide hydroxamic acid against LPS-induced septic shock in rodents.

Li Y, Liu B, Zhao H, Sailhamer EA, Fukudome EY, Zhang X, Kheirbek T, Finkelstein RA, Velmahos GC, deMoya M, Hales CA, Alam HB.

Shock. 2009 Nov;32(5):517-23. doi: 10.1097/SHK.0b013e3181a44c79.

PMID:
19295477
11.

Environmental signals controlling production of hemagglutinin/protease in Vibrio cholerae.

Benitez JA, Silva AJ, Finkelstein RA.

Infect Immun. 2001 Oct;69(10):6549-53.

12.
14.

Cholera toxin B subunit activates arachidonic acid metabolism.

Peterson JW, Finkelstein RA, Cantu J, Gessell DL, Chopra AK.

Infect Immun. 1999 Feb;67(2):794-9.

15.

The Vibrio cholerae mannose-sensitive hemagglutinin is the receptor for a filamentous bacteriophage from V. cholerae O139.

Jouravleva EA, McDonald GA, Marsh JW, Taylor RK, Boesman-Finkelstein M, Finkelstein RA.

Infect Immun. 1998 Jun;66(6):2535-9.

16.

Characterization and possible functions of a new filamentous bacteriophage from Vibrio cholerae O139.

Jouravleva EA, McDonald GA, Garon CF, Boesman-Finkelstein M, Finkelstein RA.

Microbiology. 1998 Feb;144 ( Pt 2):315-24.

PMID:
9493369
17.

Adherence of Vibrio cholerae to cultured differentiated human intestinal cells: an in vitro colonization model.

Bénitez JA, Spelbrink RG, Silva A, Phillips TE, Stanley CM, Boesman-Finkelstein M, Finkelstein RA.

Infect Immun. 1997 Aug;65(8):3474-7.

18.

Colonial opacity variations among the choleragenic vibrios.

Finkelstein RA, Boesman-Finkelstein M, Sengupta DK, Page WJ, Stanley CM, Phillips TE.

Microbiology. 1997 Jan;143 ( Pt 1):23-34.

PMID:
9025275
19.

Tagging a Vibrio cholerae El Tor candidate vaccine strain by disruption of its hemagglutinin/protease gene using a novel reporter enzyme: Clostridium thermocellum endoglucanase A.

Robert A, Silva A, Benitez JA, Rodriguez BL, Fando R, Campos J, Sengupta DK, Boesman-Finkelstein M, Finkelstein RA.

Vaccine. 1996 Nov;14(16):1517-22.

PMID:
9014293
20.

A nontoxic chimeric cholera toxin analog.

Boesman-Finkelstein M, Peterson JW, Thai LS, Finkelstein RA.

Ann N Y Acad Sci. 1996 Oct 25;797:266-8. No abstract available.

PMID:
8993375
21.

A nontoxic cholera enterotoxin (CT) analog is chimeric with regard to both epitypes of CT-B subunits, CT-B-1 and CT-B-2.

Boesman-Finkelstein M, Peterson JW, Thai LS, Finkelstein RA.

Infect Immun. 1996 Jan;64(1):346-8.

22.

Antibody against the capsule of Vibrio cholerae O139 protects against experimental challenge.

Sengupta DK, Boesman-Finkelstein M, Finkelstein RA.

Infect Immun. 1996 Jan;64(1):343-5.

23.

Why do we not yet have a suitable vaccine against cholera?

Finkelstein RA.

Adv Exp Med Biol. 1995;371B:1633-40. Review.

PMID:
7502872
24.
25.

Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.

Häse CC, Thai LS, Boesman-Finkelstein M, Mar VL, Burnette WN, Kaslow HR, Stevens LA, Moss J, Finkelstein RA.

Infect Immun. 1994 Aug;62(8):3051-7.

26.

Bacterial extracellular zinc-containing metalloproteases.

Häse CC, Finkelstein RA.

Microbiol Rev. 1993 Dec;57(4):823-37. Review.

28.
29.

Combating epidemic cholera.

Finkelstein RA.

Science. 1992 Aug 14;257(5072):862. No abstract available.

PMID:
1502547
31.

Vibrio cholerae hemagglutinin/protease, colonial variation, virulence, and detachment.

Finkelstein RA, Boesman-Finkelstein M, Chang Y, Häse CC.

Infect Immun. 1992 Feb;60(2):472-8.

32.

Heterogeneity of immunotypes of heat-labile enterotoxins of enterotoxigenic Escherichia coli of human origin.

Qu ZH, Boesman-Finkelstein M, Kazemi M, Finkelstein RA.

J Infect Dis. 1991 Oct;164(4):796-9.

PMID:
1894939
33.

Mapping epitopic regions of cholera toxin B-subunit protein.

Kazemi M, Finkelstein RA.

Mol Immunol. 1991 Aug;28(8):865-76.

PMID:
1715029
35.

Urea-induced release of heat-labile enterotoxin from Escherichia coli.

Qu ZH, Boesman-Finkelstein M, Finkelstein RA.

J Clin Microbiol. 1991 Apr;29(4):773-7.

36.

Bovine lactogenic immunity against pediatric enteropathogens.

Boesman-Finkelstein M, Finkelstein RA.

Adv Exp Med Biol. 1991;310:361-7. Review. No abstract available.

PMID:
1809011
37.

Identification of epitopes of the receptor binding subunit of cholera toxin by synthetic peptide and CBIB approaches.

Kazemi M, Finkelstein RA.

Adv Exp Med Biol. 1991;303:249-54. No abstract available.

PMID:
1725236
38.

Molecular cloning and nucleotide sequence analysis of cholera toxin genes of the CtxA- Vibrio cholerae strain Texas Star-SR.

Brickman TJ, Boesman-Finkelstein M, Finkelstein RA, McIntosh MA.

Infect Immun. 1990 Dec;58(12):4142-4.

39.
40.
41.
42.

Passive oral immunisation of children.

Boesman-Finkelstein M, Finkelstein RA.

Lancet. 1989 Dec 2;2(8675):1336. No abstract available.

PMID:
2574282
43.

Purification and characterization of a protease produced by Vibrio cholerae non-O1 and comparison with a protease of V. cholerae O1.

Honda T, Lertpocasombat K, Hata A, Miwatani T, Finkelstein RA.

Infect Immun. 1989 Sep;57(9):2799-803.

44.

Inhibition of enteropathogenic bacteria by human milk whey in vitro.

Dolan SA, Boesman-Finkelstein M, Finkelstein RA.

Pediatr Infect Dis J. 1989 Jul;8(7):430-6.

PMID:
2787902
45.

Bovine lactogenic immunity against cholera toxin-related enterotoxins and Vibrio cholerae outer membranes.

Boesman-Finkelstein M, Walton NE, Finkelstein RA.

Infect Immun. 1989 Apr;57(4):1227-34.

46.

Antigenic determinants of the cholera/coli family of enterotoxins.

Finkelstein RA, Burks MF, Zupan A, Dallas WS, Jacob CO, Ludwig DS.

Rev Infect Dis. 1987 Sep-Oct;9 Suppl 5:S490-502.

PMID:
2446368
47.

Anti-idiotypic antibodies as probes of protein active sites: application to cholera toxin subunit B.

Ludwig DS, Finkelstein RA, Karu AE, Dallas WS, Ashby ER, Schoolnik GK.

Proc Natl Acad Sci U S A. 1987 Jun;84(11):3673-7.

48.

Epitopes of the cholera family of enterotoxins.

Finkelstein RA, Burks MF, Zupan A, Dallas WS, Jacob CO, Ludwig DS.

Rev Infect Dis. 1987 May-Jun;9(3):544-61.

PMID:
2440089
49.

Evaluation of immuno-dot-blot assay for detection of cholera-related enterotoxin antigen in Salmonella typhimurium.

Panigrahi D, Burks M, Hariharan H, Finkelstein RA.

J Clin Microbiol. 1987 Apr;25(4):702-5.

50.

Comparative study of Vibrio cholerae non-O1 protease and soluble hemagglutinin with those of Vibrio cholerae O1.

Honda T, Booth BA, Boesman-Finkelstein M, Finkelstein RA.

Infect Immun. 1987 Feb;55(2):451-4.

Supplemental Content

Loading ...
Support Center